SUBSCRIBE
SUBSCRIBE
News   Policy

Ranbaxy Laboratories Gains in Mumbai After U.S. Withdraws Motion

October 9, 2008 | 
1 min read
Oct. 8 (Bloomberg) -- Ranbaxy Laboratories Ltd., the Indian drugmaker being purchased by Japan's Daiichi Sankyo Co., rose the most in almost three months after the U.S. withdrew a motion seeking to force the company to turn over audit reports.
Legal Regulatory Asia
MORE ON THIS TOPIC
The white plane flies against the blue sky, leaving a white trail. Vector illustration
FDA
FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit
May 7, 2026
 · 
3 min read
 · 
Heather McKenzie
Businessman confuse others with jargon in speech bubble dialogue
FDA
Sanofi requests removal of Tzield from CNPV program after Høeg gets involved
May 7, 2026
 · 
4 min read
 · 
Heather McKenzie
Business negotiation and cooperation vector concept. Symbol of a deal, handshake, success. Minimal design eps10 illustration.
Weight loss
GSK goes beyond weight-loss with $1B buyout of Chinese siRNA specialist
May 7, 2026
 · 
2 min read
 · 
Tristan Manalac
screenshot of Marty Makary speaking on the Megyn Kelly Show
Policy
Makary defends Replimune melanoma rejection again as FDA tensions build
May 6, 2026
 · 
3 min read
 · 
Tristan Manalac